reprocessed devices
-
$147 Million Verdict for AMDR Member Innovative Health in Case Against Johnson & Johnson’s Biosense Webster Medical Tech Unit
A federal jury in Santa Ana ruled in favor of medical device reprocessor Innovative Health in its antitrust case against Johnson & Johnson, finding subsidiary Biosense Webster illegally withheld clinical support from hospitals using reprocessed single-use devices (SUDs). The verdict affirms hospitals’ legal right to adopt FDA-regulated SUDs, promoting cost efficiency, sustainability, and fair competition while challenging anticompetitive tactics by original equipment manufacturers. The outcome is seen as a catalyst to dismantle practices inflating healthcare costs and stifling innovation.
